Bank Of New York Mellon Corp Forte Biosciences, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$1.07 - $1.55 $33,268 - $48,192	-31,092 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$1.21 - $2.24 $24 - $44	-20 Reduced 0.06%	31,092 $46,000
Q4 2021 Feb 11, 2022	SELL	$2.02 - $3.36 $7,538 - $12,539	-3,732 Reduced 10.71%	31,112 $67,000
Q3 2021 Nov 12, 2021	BUY	$2.96 - $36.67 $21,445 - $265,674	7,245 Added 26.25%	34,844 $103,000
Q2 2021 Aug 11, 2021	BUY	$31.5 - $42.5 $685,251 - $924,545	21,754 Added 372.18%	27,599 $927,000
Q4 2020 Feb 09, 2021	BUY	$28.66 - $46.79 $167,517 - $273,487	5,845 New	5,845 $212,000

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$977,456
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $114M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.